No Ordinary Subjects

No Ordinary Subjects Sat, 07 Mar 2026 14:36:08 -0500 https://noordinarysubjects.buzzsprout.com en-us © 2026 No Ordinary Subjects yes 28f825bd-c426-5541-b6f2-0a4bff02b3fb Allison Kalloo episodic false Welcome to 'No Ordinary Subjects,' a new health, medicine, and clinical research-focused podcast with a mission of shining a bright light on overlooked issues and underrepresented perspectives. Here, we aim to explore the facets and implications of diversity, equity and inclusion from the perspectives of all stakeholders. From those providing care across specialties, to individuals working tirelessly to bring new therapies to market, and the medical heroes who decide to participate in clinical trials. Whether patients or healthy volunteers— just don't call us "subjects!" Guests are the extraordinary humans in every sector of this ecosystem who are making progress possible for the rest of us. Join me on this collective journey toward better outcomes — for ALL. Feedback and suggestions for podcast topics and guests are welcome! Please share the links with those you care about, and subscribe to catch every episode on your favorite platform. Thanks in advance! #beyondlipservice

]]> Buzzsprout (https://www.buzzsprout.com) Allison Kalloo https://storage.buzzsprout.com/jsnva4ouekn0b7zlnsxgrthbkrts?.jpg No Ordinary Subjects VOICE-ACTIVATED - A Regulatory Reckoning of Authentic Engagement in Clinical Trials VOICE-ACTIVATED - A Regulatory Reckoning of Authentic Engagement in Clinical Trials In this follow-up to my keynote presentation at the meeting of the North Carolina Regulatory Affairs Forum (NCRAF) in conjunction with the Triangle Chapter of the ACRP, I’m reflecting— full-chested and unfiltered— on what it means to be voice-activated in an ecosystem that still hasn’t gotten the memo. Among other themes, I’m talking about the fallacy of “coercion” when it comes to compensating participants. I’m calling out the lazy copy/paste of outdated inclusion/exclusion criteria that keep too many out—and keep our data from ever being truly equitable or personalized. I’m challenging regulatory professionals to take action with something as simple and impactful as a “find and replace” to retire the word subject once and for all.

This isn’t just critique. It’s a call to courage. A love letter to those of us who’ve been in the research chair— and a charge to those in power to shift how we show up.

This was only the tip of the iceberg… and now it’s time to melt what’s been frozen far too long. Get the 'voice-activated' t-shirt to demonstrate your intentions. Read my 'Equity 'N Action' newsletter article on LinkedIn on the same topic. Still more at www.allisonkalloo.me.

#VoiceActivated #ClinicalResearchReckoning #NCRAF #ACRP #NCRAF2025 #ACRPVoices #ParticipantPerspective #RegulatoryReformNow #CompensateFairly #InclusionNotIllusion #FindAndReplace #DataWithDignity #EthicsInAction #TechForTrust #TrialParticipantsMatter #Partners #ICF #Coercion #Compensation #IECriteria #ProtocolDesign #Bias #BakedInBias #PersonalizedMedicine #Iceberg

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> In this follow-up to my keynote presentation at the meeting of the North Carolina Regulatory Affairs Forum (NCRAF) in conjunction with the Triangle Chapter of the ACRP, I’m reflecting— full-chested and unfiltered— on what it means to be voice-activated in an ecosystem that still hasn’t gotten the memo. Among other themes, I’m talking about the fallacy of “coercion” when it comes to compensating participants. I’m calling out the lazy copy/paste of outdated inclusion/exclusion criteria that keep too many out—and keep our data from ever being truly equitable or personalized. I’m challenging regulatory professionals to take action with something as simple and impactful as a “find and replace” to retire the word subject once and for all.

This isn’t just critique. It’s a call to courage. A love letter to those of us who’ve been in the research chair— and a charge to those in power to shift how we show up.

This was only the tip of the iceberg… and now it’s time to melt what’s been frozen far too long. Get the 'voice-activated' t-shirt to demonstrate your intentions. Read my 'Equity 'N Action' newsletter article on LinkedIn on the same topic. Still more at www.allisonkalloo.me.

#VoiceActivated #ClinicalResearchReckoning #NCRAF #ACRP #NCRAF2025 #ACRPVoices #ParticipantPerspective #RegulatoryReformNow #CompensateFairly #InclusionNotIllusion #FindAndReplace #DataWithDignity #EthicsInAction #TechForTrust #TrialParticipantsMatter #Partners #ICF #Coercion #Compensation #IECriteria #ProtocolDesign #Bias #BakedInBias #PersonalizedMedicine #Iceberg

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Kalloo Buzzsprout-17067187 Tue, 29 Apr 2025 16:00:00 -0400 774 2 9 full false TRUTH, Not Trust, Is the REAL Currency in Clinical Trials TRUTH, Not Trust, Is the REAL Currency in Clinical Trials In this episode, I touch on why truth, not just trust, is essential in clinical research. I challenge the status quo, advocating for radical transparency to empower participants and build genuine engagement. Read my more in-depth article in the newsletter, Equity 'n Action on LinkedIn.

#MedicalResearch #Healthcare #TransparencyInResearch #TruthInTrials #ResearchEthics #CommunityEngagement #RadicalTransparency #NoOrdinarySubjects #AllisonKalloo #ResearchTransparency #BeyondTrust #MarginalizedCommunities #SystemicInequality #HistoricalTraumaInResearch #DEIinResearch #DataTransparency #AskTheQuestions #DemandTransparency #InformedChoice #PowerToThePeople #April2025

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> In this episode, I touch on why truth, not just trust, is essential in clinical research. I challenge the status quo, advocating for radical transparency to empower participants and build genuine engagement. Read my more in-depth article in the newsletter, Equity 'n Action on LinkedIn.

#MedicalResearch #Healthcare #TransparencyInResearch #TruthInTrials #ResearchEthics #CommunityEngagement #RadicalTransparency #NoOrdinarySubjects #AllisonKalloo #ResearchTransparency #BeyondTrust #MarginalizedCommunities #SystemicInequality #HistoricalTraumaInResearch #DEIinResearch #DataTransparency #AskTheQuestions #DemandTransparency #InformedChoice #PowerToThePeople #April2025

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Kalloo Buzzsprout-17010388 Mon, 21 Apr 2025 07:00:00 -0400 646 2 8 bonus false Contagion of Doubt: How Misinformation Brought Measles Back Contagion of Doubt: How Misinformation Brought Measles Back This episode of No Ordinary Subjects confronts the return of measles in the United States— a disease we once eliminated. We explore how rising vaccine hesitancy, fueled by years of politicized misinformation and erosion of public trust, has weakened our collective defenses and put us back at risk. Drawing connections between the sidelining of science during the COVID pandemic and today’s outbreaks, we dig into what herd immunity means, who gets left behind and at risk when it's compromised, and why protecting public health demands reconciliation with science-based expertise and the facts.

#NoOrdinarySubjects #Measles #Vaccination #Immunity #Outbreak
#PublicHealth #PublicHealthCrisis #HerdImmunity #VaccineHesitancy
#TrustScience #ScienceNotSilence #StopTheSpread #MisinformationKills
#ProtectOurKids #HealthEquity #HealthJustice #CommunityImmunity
#FactsMatter #ThisIsPreventable #WakeUpCall #ReclaimPublicHealth

Send a text

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> This episode of No Ordinary Subjects confronts the return of measles in the United States— a disease we once eliminated. We explore how rising vaccine hesitancy, fueled by years of politicized misinformation and erosion of public trust, has weakened our collective defenses and put us back at risk. Drawing connections between the sidelining of science during the COVID pandemic and today’s outbreaks, we dig into what herd immunity means, who gets left behind and at risk when it's compromised, and why protecting public health demands reconciliation with science-based expertise and the facts.

#NoOrdinarySubjects #Measles #Vaccination #Immunity #Outbreak
#PublicHealth #PublicHealthCrisis #HerdImmunity #VaccineHesitancy
#TrustScience #ScienceNotSilence #StopTheSpread #MisinformationKills
#ProtectOurKids #HealthEquity #HealthJustice #CommunityImmunity
#FactsMatter #ThisIsPreventable #WakeUpCall #ReclaimPublicHealth

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Kalloo Buzzsprout-16972793 Mon, 14 Apr 2025 08:00:00 -0400 1363 full false The 2025 Reckoning: Refusing to Rewrite History The 2025 Reckoning: Refusing to Rewrite History In this episode of No Ordinary Subjects, host Allison Kalloo unpacks the dangerous implications of the Trump administration’s latest executive order, Restoring Truth and Sanity to American History, which takes direct aim at the Smithsonian Institution—specifically, the National Museum of African American History and Culture. This isn’t just about rewriting history; it’s about erasing it.

We explore how this calculated attack on historical integrity threatens not only cultural institutions but also industries that rely on truth—healthcare, technology, and business. What happens when systemic erasure extends to medical research, clinical trials, and AI development? What’s at stake when Black contributions are deliberately excluded from the national consciousness?

This episode is a call to action. Beyond passive allyship, we discuss what it means to be an accomplice in the fight for truth. Because neutrality is not an option when history itself is under siege.

Join the conversation.

Send a text

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> In this episode of No Ordinary Subjects, host Allison Kalloo unpacks the dangerous implications of the Trump administration’s latest executive order, Restoring Truth and Sanity to American History, which takes direct aim at the Smithsonian Institution—specifically, the National Museum of African American History and Culture. This isn’t just about rewriting history; it’s about erasing it.

We explore how this calculated attack on historical integrity threatens not only cultural institutions but also industries that rely on truth—healthcare, technology, and business. What happens when systemic erasure extends to medical research, clinical trials, and AI development? What’s at stake when Black contributions are deliberately excluded from the national consciousness?

This episode is a call to action. Beyond passive allyship, we discuss what it means to be an accomplice in the fight for truth. Because neutrality is not an option when history itself is under siege.

Join the conversation.

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Kalloo Buzzsprout-16900428 Tue, 01 Apr 2025 17:00:00 -0400 1144 2 10 full false Guidance with Teeth - Why the FDA Needs Enforcement Power Guidance with Teeth - Why the FDA Needs Enforcement Power In this episode of No Ordinary Subjects, host Allison Kalloo exposes a critical flaw in how clinical trials are regulated in the U.S. The FDA can issue guidance, make recommendations, and encourage diversity— but it lacks the power to enforce meaningful change. Without Congressional action, clinical trial sponsors can continue treating inclusion as optional. It’s time to demand more than suggestions. Tune in for a frank discussion on why the FDA needs real authority and what’s at stake if we keep accepting business as usual. Read the companion article on LinkedIn.

#NoOrdinarySubjects #RegulatoryPower #PatientAdvocacy #PublicHealth #HealthcarePolicy #DrugApproval

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> In this episode of No Ordinary Subjects, host Allison Kalloo exposes a critical flaw in how clinical trials are regulated in the U.S. The FDA can issue guidance, make recommendations, and encourage diversity— but it lacks the power to enforce meaningful change. Without Congressional action, clinical trial sponsors can continue treating inclusion as optional. It’s time to demand more than suggestions. Tune in for a frank discussion on why the FDA needs real authority and what’s at stake if we keep accepting business as usual. Read the companion article on LinkedIn.

#NoOrdinarySubjects #RegulatoryPower #PatientAdvocacy #PublicHealth #HealthcarePolicy #DrugApproval

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Kalloo Buzzsprout-16819914 Fri, 21 Mar 2025 16:00:00 -0400 960 2 9 trailer false The Plasma Paradox - The Ethics of Industry Profits & Donor Compensation The Plasma Paradox - The Ethics of Industry Profits & Donor Compensation This episode of No Ordinary Subjects gets into the ethical complexities of the $24 billion plasma donation industry and the "Plasma Paradox": the vast financial gap between donor compensation and the multi-thousand dollar value of plasma-derived pharmaceuticals that come from each liter extracted. Examining the fairness of corporate profits versus donor payouts, also consider the long-term health effects of frequent plasma extraction. The episode covers the history of plasma use and life-saving therapies, financial disparities, and ethical concerns, and calls for more regulation, transparency, community investment, informed consent, and equitable compensation. There is credence in challenging the idea that altruism negates fair pay. This is a rallying cry for a system that truly values donors and the vital role they play in access to better health outcomes.

#PlasmaDonation #EthicalDilemmas #HealthcareEquity #MedicalEthics #PharmaceuticalIndustry #DonorCompensation #BloodPlasma #HumanRights #MedicalResearch #IndustryProfits #VulnerablePopulations #InformedConsent #MedicalJustice #HealthDisparities #EconomicVulnerability #HenriettaLacks #AltruismVsProfit #PatientRights #MedicalRegulation #NoOrdinarySubjects #BloodDonation #Healthcare #DonorRights #PatientRights #HealthEquity #Pharmaceuticals #CommunityHealth #FairCompensation #EconomicJustice #HealthAccess #MedicalIndustry #HealthAwareness #DonatePlasma #DonateBlood #MedicalDebate #HealthPolicy #PublicHealth #PlasmaIndustry #BloodIndustry #MedicalProfits #DonorExploitation #MedicalTransparency #HealthcareReform #Bioethics #MedicalInnovation #DrugPricing #HealthEconomics #ClinicalTrials #MedicalAdvocacy #HealthcareForAll #HealthJustice #health #blood #plasma #donation #savealife #hemoglobin #protein #iron #sicklecell #plasmaexchange #deficiencydisease #hemophilia #PID #immunodeficiencydisease #IGtherapy #pharma #medicine #justice #equity #medicalethics #donateplasma #poverty #SDOH #socialdeterminantsofhealth

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> This episode of No Ordinary Subjects gets into the ethical complexities of the $24 billion plasma donation industry and the "Plasma Paradox": the vast financial gap between donor compensation and the multi-thousand dollar value of plasma-derived pharmaceuticals that come from each liter extracted. Examining the fairness of corporate profits versus donor payouts, also consider the long-term health effects of frequent plasma extraction. The episode covers the history of plasma use and life-saving therapies, financial disparities, and ethical concerns, and calls for more regulation, transparency, community investment, informed consent, and equitable compensation. There is credence in challenging the idea that altruism negates fair pay. This is a rallying cry for a system that truly values donors and the vital role they play in access to better health outcomes.

#PlasmaDonation #EthicalDilemmas #HealthcareEquity #MedicalEthics #PharmaceuticalIndustry #DonorCompensation #BloodPlasma #HumanRights #MedicalResearch #IndustryProfits #VulnerablePopulations #InformedConsent #MedicalJustice #HealthDisparities #EconomicVulnerability #HenriettaLacks #AltruismVsProfit #PatientRights #MedicalRegulation #NoOrdinarySubjects #BloodDonation #Healthcare #DonorRights #PatientRights #HealthEquity #Pharmaceuticals #CommunityHealth #FairCompensation #EconomicJustice #HealthAccess #MedicalIndustry #HealthAwareness #DonatePlasma #DonateBlood #MedicalDebate #HealthPolicy #PublicHealth #PlasmaIndustry #BloodIndustry #MedicalProfits #DonorExploitation #MedicalTransparency #HealthcareReform #Bioethics #MedicalInnovation #DrugPricing #HealthEconomics #ClinicalTrials #MedicalAdvocacy #HealthcareForAll #HealthJustice #health #blood #plasma #donation #savealife #hemoglobin #protein #iron #sicklecell #plasmaexchange #deficiencydisease #hemophilia #PID #immunodeficiencydisease #IGtherapy #pharma #medicine #justice #equity #medicalethics #donateplasma #poverty #SDOH #socialdeterminantsofhealth

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Kalloo Buzzsprout-16793806 Fri, 14 Mar 2025 15:00:00 -0400 1994 2 8 full false Beyond Buzzwords: DEI Guidelines for Real Clinical Trial Equity Beyond Buzzwords: DEI Guidelines for Real Clinical Trial Equity Tune in to this episode to get guidance on cutting through DEI noise to deliver actionable guidelines for clinical trial equity. Learn how to move beyond buzzwords, meet FDA expectations, and create real change. We cover lived experience, recruitment, community partnerships, data strategies, and more. We're speaking directly to Clinical Trial Operations Leaders, Regulatory Affairs professionals, Medical Affairs experts, Heads of DEI, Biotech Founders, CRO Executives, and Patient Advocates. If you're grappling with recruitment challenges, navigating evolving FDA diversity guidance, or striving for meaningful change beyond corporate statements, this episode is for you. After all, DEI in clinical trials is ultimately centered on producing better science, better business, and better patient outcomes.

#DEI #DiversityInclusion #HealthcareEquity #PatientAdvocacy #Pharma #Biotech #RegulatoryAffairs #MedicalAffairs #FDA #ClinicalResearch #HealthDisparities #CommunityHealth #DataDriven #PatientExperience #ResearchEthics #HealthInnovation #PublicHealth #ScientificResearch #HealthTech #Equity

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Tune in to this episode to get guidance on cutting through DEI noise to deliver actionable guidelines for clinical trial equity. Learn how to move beyond buzzwords, meet FDA expectations, and create real change. We cover lived experience, recruitment, community partnerships, data strategies, and more. We're speaking directly to Clinical Trial Operations Leaders, Regulatory Affairs professionals, Medical Affairs experts, Heads of DEI, Biotech Founders, CRO Executives, and Patient Advocates. If you're grappling with recruitment challenges, navigating evolving FDA diversity guidance, or striving for meaningful change beyond corporate statements, this episode is for you. After all, DEI in clinical trials is ultimately centered on producing better science, better business, and better patient outcomes.

#DEI #DiversityInclusion #HealthcareEquity #PatientAdvocacy #Pharma #Biotech #RegulatoryAffairs #MedicalAffairs #FDA #ClinicalResearch #HealthDisparities #CommunityHealth #DataDriven #PatientExperience #ResearchEthics #HealthInnovation #PublicHealth #ScientificResearch #HealthTech #Equity

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Kalloo Buzzsprout-16782932 Wed, 12 Mar 2025 20:00:00 -0400 2431 2 7 full false International Women's Day: Power & Possibility International Women's Day: Power & Possibility Our perspectives and opportunities are shaped by culture, history, and the experiences we carry. On this International Women’s Day episode of No Ordinary Subjects, we’re celebrating how these forces influence the way we move through the world— and how we can push beyond the limits they impose. It’s also about not allowing competition with one another impede our progress or diminish our community. Women are stepping fully into our power. From resilience to reinvention, women continue to transform obstacles into opportunities.

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Our perspectives and opportunities are shaped by culture, history, and the experiences we carry. On this International Women’s Day episode of No Ordinary Subjects, we’re celebrating how these forces influence the way we move through the world— and how we can push beyond the limits they impose. It’s also about not allowing competition with one another impede our progress or diminish our community. Women are stepping fully into our power. From resilience to reinvention, women continue to transform obstacles into opportunities.

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Kalloo Buzzsprout-16770636 Tue, 11 Mar 2025 06:00:00 -0400 1649 2 6 bonus false Corporate Chameleons - Adaptive DEI Rebranding Corporate Chameleons - Adaptive DEI Rebranding Lately, there’s been a shift: Companies and institutions that were always genuine about cultural change are finding themselves needing to “rebrand” diversity, equity, and inclusion (DEI) in light of the toxic political climate. But let’s be real: Is this adaptive evolution or erosion of standards? In this episode of No Ordinary Subjects, I break down the difference between meaningful transformation and the kind of corporate posturing that prioritizes optics over impact. For those genuinely deeply invested in inclusive strategies—especially in healthcare and clinical trials— you earn respect for refusing to acquiesce to the political toxicity that’s made DEI a dirty word in some circles. And for not cosigning on professional peer pressure that waters down what true equity requires. Instead, we’ll talk about what authenticity in DEI looks like, why community engagement and transparency are non-negotiable, and how we keep our eyes on the prize and move forward without losing the plot. If you’re tired of lip service and looking for real talk on DEI, this episode is for you.

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Lately, there’s been a shift: Companies and institutions that were always genuine about cultural change are finding themselves needing to “rebrand” diversity, equity, and inclusion (DEI) in light of the toxic political climate. But let’s be real: Is this adaptive evolution or erosion of standards? In this episode of No Ordinary Subjects, I break down the difference between meaningful transformation and the kind of corporate posturing that prioritizes optics over impact. For those genuinely deeply invested in inclusive strategies—especially in healthcare and clinical trials— you earn respect for refusing to acquiesce to the political toxicity that’s made DEI a dirty word in some circles. And for not cosigning on professional peer pressure that waters down what true equity requires. Instead, we’ll talk about what authenticity in DEI looks like, why community engagement and transparency are non-negotiable, and how we keep our eyes on the prize and move forward without losing the plot. If you’re tired of lip service and looking for real talk on DEI, this episode is for you.

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Kalloo Buzzsprout-16588218 Tue, 11 Feb 2025 07:00:00 -0500 1676 2 5 full false The Death of DEI? Not on MY Watch! The Death of DEI? Not on MY Watch! DEI is under attack—watered down, defunded, and dismissed. But let’s be clear: its death is neither inevitable nor acceptable. In this episode of No Ordinary Subjects, I confront the backlash against diversity, equity, and inclusion head-on, exposing the paranoid hypocrisy of those who claim DEI has "gone too far" while systemic inequities remain as stark as ever. I call out the performative gestures and demand accountability. From empty corporate pledges to outright rollbacks, I call out the administration for fueling this backlash with their paranoid, regressive narrative. DEI isn’t a trend—it’s a fixture, no matter what you want to call it. Because on my watch, silence is not an option.

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> DEI is under attack—watered down, defunded, and dismissed. But let’s be clear: its death is neither inevitable nor acceptable. In this episode of No Ordinary Subjects, I confront the backlash against diversity, equity, and inclusion head-on, exposing the paranoid hypocrisy of those who claim DEI has "gone too far" while systemic inequities remain as stark as ever. I call out the performative gestures and demand accountability. From empty corporate pledges to outright rollbacks, I call out the administration for fueling this backlash with their paranoid, regressive narrative. DEI isn’t a trend—it’s a fixture, no matter what you want to call it. Because on my watch, silence is not an option.

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Kalloo Buzzsprout-16587146 Sat, 08 Feb 2025 18:00:00 -0500 595 2 4 trailer false When Clinical Trials Fall Short: A Patient’s Unfiltered Review When Clinical Trials Fall Short: A Patient’s Unfiltered Review In a candid episode of No Ordinary Subjects, I share my personal experience of being shortchanged in a migraine clinical trial after a technical error led to a missed blood draw. The sponsor's refusal to take responsibility sparked a crucial question: why don't patients have a public platform to review clinical trials like consumers review businesses? I break the silence naming the sponsor and offering a raw patient perspective on the study demanding transparency and accountability. This episode confronts ethical oversight FDA regulations and the undervaluation of trial participants. It's a call for change urging a shift towards patient empowerment and respect within clinical research. Listen now and share your story as we advocate for patients.

#patientadvocacy #healthcarepodcast #medicalpodcast #newepisode #patientrights #clinicaltrials #clinicalresearch #researchethics #FDA #drugdevelopment #pharmaceuticals #medicalresearch #studyparticipants #trialtransparency #clinicaltrialexperience #trialreview #researchaccountability #patientexperience #informedconsent #transparency #accountability #healthcaretransparency #corporateresponsibility #patientfeedback #consumerreviews #healthcarereviews #industryaccountability #patientcompensation #medicalmistakes #migrainestudy #technicalfailure #shortchanged #undervalued #healthcaredisparities #ethicaloversight #statusquochallenge #patientempowerment #patientvoice #changehealthcare #healthcarereform #jointheconversation.

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> In a candid episode of No Ordinary Subjects, I share my personal experience of being shortchanged in a migraine clinical trial after a technical error led to a missed blood draw. The sponsor's refusal to take responsibility sparked a crucial question: why don't patients have a public platform to review clinical trials like consumers review businesses? I break the silence naming the sponsor and offering a raw patient perspective on the study demanding transparency and accountability. This episode confronts ethical oversight FDA regulations and the undervaluation of trial participants. It's a call for change urging a shift towards patient empowerment and respect within clinical research. Listen now and share your story as we advocate for patients.

#patientadvocacy #healthcarepodcast #medicalpodcast #newepisode #patientrights #clinicaltrials #clinicalresearch #researchethics #FDA #drugdevelopment #pharmaceuticals #medicalresearch #studyparticipants #trialtransparency #clinicaltrialexperience #trialreview #researchaccountability #patientexperience #informedconsent #transparency #accountability #healthcaretransparency #corporateresponsibility #patientfeedback #consumerreviews #healthcarereviews #industryaccountability #patientcompensation #medicalmistakes #migrainestudy #technicalfailure #shortchanged #undervalued #healthcaredisparities #ethicaloversight #statusquochallenge #patientempowerment #patientvoice #changehealthcare #healthcarereform #jointheconversation.

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Kalloo Buzzsprout-16584333 Fri, 07 Feb 2025 20:00:00 -0500 1162 2 3 full false Revisiting the Issue of Patient Compensation Revisiting the Issue of Patient Compensation In this solo episode of No Ordinary Subjects, I reflect on a topic close to my heart: patient compensation in clinical trials. Having stepped away from the industry, I share my candid thoughts on how the lack of respect for participants played a role in my decision. I have been an advocate for many years. A recent article by DIA brought the issue of money front and center: Compensation isn’t just financial— it’s a matter of ethics and fairness. Patients sacrifice time, health, and trust, yet their contributions continue to be undervalued in both figurative and literal ways. It’s time to reimagine clinical trials with empowerment and equity at the core. Let’s talk about what needs to change. #DIA #pharma #drugdevelopment #clinicaltrials #patient #participant #participation #clinicalresearch #financial #ethics #equity #sacrifice #decision #health #trust #compensation #playfair #transparency #researchpartner #FDA #IRB #coercion #empowerment

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> In this solo episode of No Ordinary Subjects, I reflect on a topic close to my heart: patient compensation in clinical trials. Having stepped away from the industry, I share my candid thoughts on how the lack of respect for participants played a role in my decision. I have been an advocate for many years. A recent article by DIA brought the issue of money front and center: Compensation isn’t just financial— it’s a matter of ethics and fairness. Patients sacrifice time, health, and trust, yet their contributions continue to be undervalued in both figurative and literal ways. It’s time to reimagine clinical trials with empowerment and equity at the core. Let’s talk about what needs to change. #DIA #pharma #drugdevelopment #clinicaltrials #patient #participant #participation #clinicalresearch #financial #ethics #equity #sacrifice #decision #health #trust #compensation #playfair #transparency #researchpartner #FDA #IRB #coercion #empowerment

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Kalloo Buzzsprout-16417384 Fri, 24 Jan 2025 15:00:00 -0500 1373 full false Need to Get Unstuck? Just Start Need to Get Unstuck? Just Start Feeling stuck? Overwhelmed by where to begin? Both are more common than a cold. In this episode of No Ordinary Subjects, host Allison Kalloo dives into the power of taking that all-important first step toward your passion. Whether you’re launching a new project, pursuing a dream, or simply rethinking what’s possible, the message is clear: you don’t have to have it all figured out to get started.

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Feeling stuck? Overwhelmed by where to begin? Both are more common than a cold. In this episode of No Ordinary Subjects, host Allison Kalloo dives into the power of taking that all-important first step toward your passion. Whether you’re launching a new project, pursuing a dream, or simply rethinking what’s possible, the message is clear: you don’t have to have it all figured out to get started.

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Kalloo Buzzsprout-16365498 Wed, 01 Jan 2025 05:00:00 -0500 573 1 9 bonus false 2024 Year-End Wrap-Up 2024 Year-End Wrap-Up As the year comes to a close, host Allison Kalloo reflects on the challenges, growth, and clarity 2024 brought while setting an inspiring tone for 2025. In this deeply personal episode, Allison shares stories from her journey, including lessons on communication and the power of human connection.

She dives into her multi-passionate goals: writing books, launching apps, designing CVSTOMOLOGY products, and more— showing how science and the arts can intersect to create meaningful impact. With a powerful call-to-action for the pharmaceutical and healthcare industries, Allison challenges listeners to stop the lip service and truly show up to make a difference.

This episode is more than a year-end reflection; it’s an invitation to explore your passions, embrace your purpose, and connect with yourself and others in transformative ways. Whether you’re chasing a dream or rethinking your impact, this conversation will leave you motivated to make 2024 your most intentional year yet.

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> As the year comes to a close, host Allison Kalloo reflects on the challenges, growth, and clarity 2024 brought while setting an inspiring tone for 2025. In this deeply personal episode, Allison shares stories from her journey, including lessons on communication and the power of human connection.

She dives into her multi-passionate goals: writing books, launching apps, designing CVSTOMOLOGY products, and more— showing how science and the arts can intersect to create meaningful impact. With a powerful call-to-action for the pharmaceutical and healthcare industries, Allison challenges listeners to stop the lip service and truly show up to make a difference.

This episode is more than a year-end reflection; it’s an invitation to explore your passions, embrace your purpose, and connect with yourself and others in transformative ways. Whether you’re chasing a dream or rethinking your impact, this conversation will leave you motivated to make 2024 your most intentional year yet.

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Kalloo Buzzsprout-16364316 Tue, 31 Dec 2024 19:00:00 -0500 1321 1 8 full false Grace & Grit - Navigating Breast Cancer with Lady Kimberly Grace & Grit - Navigating Breast Cancer with Lady Kimberly In this episode of 'No Ordinary Subjects', we hear from 'Lady' Kimberly Anderson, whose breast cancer journey is a remarkable testament to both grace and grit. Diagnosed at the young age of 32, Lady Kimberly is forthcoming about her harrowing experience and what (and who) has kept her going in the 15 years since. She's happy to discuss the importance of leaning on family, faith, community, and a lot of creativity along the way. She shares her strong opinions across a variety a lot of topics, including chemotherapy, vaccines, and clinical trials. "More than a conqueror," she is an inspiration for how to live well with clarity and a sense of purpose. Don't miss this heartfelt episode. #heart #warrior #survivor #conqueror #breastcancer #straighttalk #clinicaltrials #clinicalresearch #support #faith #family #community #advocacy #creativity #survival #blessings #diagnosis #ambassador #USCongress #FDA #DEI #diversityguidance

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> In this episode of 'No Ordinary Subjects', we hear from 'Lady' Kimberly Anderson, whose breast cancer journey is a remarkable testament to both grace and grit. Diagnosed at the young age of 32, Lady Kimberly is forthcoming about her harrowing experience and what (and who) has kept her going in the 15 years since. She's happy to discuss the importance of leaning on family, faith, community, and a lot of creativity along the way. She shares her strong opinions across a variety a lot of topics, including chemotherapy, vaccines, and clinical trials. "More than a conqueror," she is an inspiration for how to live well with clarity and a sense of purpose. Don't miss this heartfelt episode. #heart #warrior #survivor #conqueror #breastcancer #straighttalk #clinicaltrials #clinicalresearch #support #faith #family #community #advocacy #creativity #survival #blessings #diagnosis #ambassador #USCongress #FDA #DEI #diversityguidance

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Kalloo Buzzsprout-15197201 Wed, 05 Jun 2024 08:00:00 -0400 4305 1 7 full false Health Equity Congress - Patient Perspectives - Part 1 Health Equity Congress - Patient Perspectives - Part 1 The 2nd Annual Health Equity in Clinical Trials Congress took place in Atlanta, GA on May 8-9, 2024. I'm your podcast host, Allison Kalloo, and I moderated the opening plenary session— a panel featuring patients like me! Not surprisingly, the time constraints did not allow for as robust a conversation as we would have liked, so it felt as if we were just scratching the surface of what we wanted to share with the audience of mostly pharma representatives. But... 'No Ordinary Subjects' seems like a great platform for taking a deeper dive. I also mention the #Medable digital eConsent as one of the potential solutions to the barriers we experience. [Full disclosure: I have served on Medable's Patient Advisory Council/Patient Caregiver Network for about 4 years.] #HECT #pharma #clinicaltrials @HealthEquityCongress #healthequity #conference #health #equity #patient #participant #caregiver #network #FDA #research #clinicalresearch

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> The 2nd Annual Health Equity in Clinical Trials Congress took place in Atlanta, GA on May 8-9, 2024. I'm your podcast host, Allison Kalloo, and I moderated the opening plenary session— a panel featuring patients like me! Not surprisingly, the time constraints did not allow for as robust a conversation as we would have liked, so it felt as if we were just scratching the surface of what we wanted to share with the audience of mostly pharma representatives. But... 'No Ordinary Subjects' seems like a great platform for taking a deeper dive. I also mention the #Medable digital eConsent as one of the potential solutions to the barriers we experience. [Full disclosure: I have served on Medable's Patient Advisory Council/Patient Caregiver Network for about 4 years.] #HECT #pharma #clinicaltrials @HealthEquityCongress #healthequity #conference #health #equity #patient #participant #caregiver #network #FDA #research #clinicalresearch

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Kalloo Buzzsprout-15140115 Sun, 26 May 2024 19:00:00 -0400 945 1 6 full false Rural Health Advocacy - Patricia Peele Rural Health Advocacy - Patricia Peele On this episode of No Ordinary Subjects, host Allison Kalloo sits down with the remarkable Ms. Patricia Peele, a community activist and advocate from rural Halifax County, North Carolina. Patricia's story is one of inspiration and action, dedicated to increasing representation in clinical trials for Black, Brown, and rural communities. She shares her invaluable insights and practical advice for bridging the gap and fostering trust between researchers and these often-underrepresented populations. Patricia's firsthand experience as a research participant, coupled with her deep understanding of community needs, makes her a powerful voice in the fight for health equity. Join us as we explore the challenges and opportunities in clinical trial participation, and learn how we can work together to create a more inclusive and representative research landscape. Patricia's wisdom and passion are contagious, and this is an episode you won't want to miss. #ClinicalTrials #HealthEquity #DiversityInResearch #RuralHealth #CommunityEngagement #PatientAdvocacy #BlackHealth #BrownHealth #HealthDisparities #ResearchParticipation #InclusionInResearch #NoOrdinarySubjects #Podcast #HealthPodcast #NorthCarolina #HalifaxCounty #CommunityActivist #PatientExperience #RepresentationMatters #HealthResearch #MedicalResearch #ClinicalResearch

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> On this episode of No Ordinary Subjects, host Allison Kalloo sits down with the remarkable Ms. Patricia Peele, a community activist and advocate from rural Halifax County, North Carolina. Patricia's story is one of inspiration and action, dedicated to increasing representation in clinical trials for Black, Brown, and rural communities. She shares her invaluable insights and practical advice for bridging the gap and fostering trust between researchers and these often-underrepresented populations. Patricia's firsthand experience as a research participant, coupled with her deep understanding of community needs, makes her a powerful voice in the fight for health equity. Join us as we explore the challenges and opportunities in clinical trial participation, and learn how we can work together to create a more inclusive and representative research landscape. Patricia's wisdom and passion are contagious, and this is an episode you won't want to miss. #ClinicalTrials #HealthEquity #DiversityInResearch #RuralHealth #CommunityEngagement #PatientAdvocacy #BlackHealth #BrownHealth #HealthDisparities #ResearchParticipation #InclusionInResearch #NoOrdinarySubjects #Podcast #HealthPodcast #NorthCarolina #HalifaxCounty #CommunityActivist #PatientExperience #RepresentationMatters #HealthResearch #MedicalResearch #ClinicalResearch

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Kalloo Buzzsprout-15105199 Mon, 20 May 2024 21:00:00 -0400 3354 1 5 full false Unraveling Male Lupus - VERY Extended Interview Unraveling Male Lupus - VERY Extended Interview This extended, deeply personal episode of No Ordinary Subjects features a courageous conversation with a man who bravely shares his journey with lupus. For too long, lupus has been mistakenly perceived as a "women's disease," leaving men who experience it feeling isolated and misunderstood. Our anonymous guest opens up about his life before diagnosis, the challenges he faced in getting answers, and the unique struggles he's encountered as a man living with this chronic illness. He offers an unfiltered look at the realities of male lupus, from the physical and emotional toll to the societal stigma that often accompanies it. His story is one of resilience and hope, highlighting the importance of support, understanding, and connection. This powerful interview also inadvertently demonstrates the rich insights and potential benefits available to the pharmaceutical and healthcare industries when genuine interpersonal rapport is established with patients. Join us for this important conversation as we shed light on male lupus and amplify the voices that need to be heard. When people want to talk, you let them. #Lupus #MaleLupus #ChronicIllness #AutoimmuneDisease #InvisibleIllness #HealthStigma #PatientStories #PatientExperience #HealthAdvocacy #LupusAwareness #MenHealth #ChronicPain #FDA #pharma #clinicaltrials #trials #clinicalresearch #patientperspective #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalPodcast #RareDisease #AutoimmuneAwareness #HealthJourney #Resilience #Support #Understanding #lupusstrong

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> This extended, deeply personal episode of No Ordinary Subjects features a courageous conversation with a man who bravely shares his journey with lupus. For too long, lupus has been mistakenly perceived as a "women's disease," leaving men who experience it feeling isolated and misunderstood. Our anonymous guest opens up about his life before diagnosis, the challenges he faced in getting answers, and the unique struggles he's encountered as a man living with this chronic illness. He offers an unfiltered look at the realities of male lupus, from the physical and emotional toll to the societal stigma that often accompanies it. His story is one of resilience and hope, highlighting the importance of support, understanding, and connection. This powerful interview also inadvertently demonstrates the rich insights and potential benefits available to the pharmaceutical and healthcare industries when genuine interpersonal rapport is established with patients. Join us for this important conversation as we shed light on male lupus and amplify the voices that need to be heard. When people want to talk, you let them. #Lupus #MaleLupus #ChronicIllness #AutoimmuneDisease #InvisibleIllness #HealthStigma #PatientStories #PatientExperience #HealthAdvocacy #LupusAwareness #MenHealth #ChronicPain #FDA #pharma #clinicaltrials #trials #clinicalresearch #patientperspective #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalPodcast #RareDisease #AutoimmuneAwareness #HealthJourney #Resilience #Support #Understanding #lupusstrong

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Kalloo Buzzsprout-15070875 Tue, 14 May 2024 21:00:00 -0400 12728 1 3 full false Diversity Patient Recruitment - Hiding in Plain Sight Diversity Patient Recruitment - Hiding in Plain Sight This episode of No Ordinary Subjects offers a deeply personal reflection from your host. I'm Allison Kalloo and I decided to share a powerful encounter that has shaped her understanding of bias in research. Taking a trip down memory lane, I recountsan experience that underscores the fundamental biases that can hinder researchers and their work from achieving true greatness and inclusivity. Rather than dwelling on the problem, this episode offers a valuable teachable moment. It serves as a reminder that moving beyond the limitations of our cultural comfort zones requires stepping down from the 'ivory tower' and actively getting out of our own way. Join me as I explore this critical issue and offer insights on how we can create a more equitable and representative research landscape. #ClinicalTrials #BiasInResearch #HealthEquity #DiversityInResearch #ResearchBias #InclusionInResearch #FDA #IRB #NIH #Congress #HealthPolicy #HealthDisparities #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #PatientExperience #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthInnovation #ResearchEthics #EquityInHealth

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> This episode of No Ordinary Subjects offers a deeply personal reflection from your host. I'm Allison Kalloo and I decided to share a powerful encounter that has shaped her understanding of bias in research. Taking a trip down memory lane, I recountsan experience that underscores the fundamental biases that can hinder researchers and their work from achieving true greatness and inclusivity. Rather than dwelling on the problem, this episode offers a valuable teachable moment. It serves as a reminder that moving beyond the limitations of our cultural comfort zones requires stepping down from the 'ivory tower' and actively getting out of our own way. Join me as I explore this critical issue and offer insights on how we can create a more equitable and representative research landscape. #ClinicalTrials #BiasInResearch #HealthEquity #DiversityInResearch #ResearchBias #InclusionInResearch #FDA #IRB #NIH #Congress #HealthPolicy #HealthDisparities #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #PatientExperience #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthInnovation #ResearchEthics #EquityInHealth

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Kalloo Buzzsprout-15069730 Tue, 14 May 2024 17:00:00 -0400 581 1 2 full false PREMIERE Episode PREMIERE Episode Stepping out of the long shadows of myths, misconceptions, and misalignment, No Ordinary Subjects connects the dots and clears a path toward better outcomes in clinical trials – for everyone involved. The status quo is not acceptable, and it's simply not working. It's time to put the pedal down and explore meaningful solutions for all stakeholders in this vital ecosystem: clinical researchers, biopharma, regulatory agencies, CROs, clinical sites and their dedicated staff – with a laser focus on the implications for and impact on study participants, particularly those who have been historically underrepresented in clinical trials.

Join host Allison Kalloo, who has a vested interest in the conversation, the process, and the outcomes, as she embarks on this crucial journey. This premiere episode lays the groundwork for a series of thought-provoking discussions that challenge the status quo and champion innovative approaches to clinical research. Allison believes, and we believe, that you have a vested interest in these conversations too. What topics are most important to you? Reach out and let us know! Let's shape the future of clinical trials together. #ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Stepping out of the long shadows of myths, misconceptions, and misalignment, No Ordinary Subjects connects the dots and clears a path toward better outcomes in clinical trials – for everyone involved. The status quo is not acceptable, and it's simply not working. It's time to put the pedal down and explore meaningful solutions for all stakeholders in this vital ecosystem: clinical researchers, biopharma, regulatory agencies, CROs, clinical sites and their dedicated staff – with a laser focus on the implications for and impact on study participants, particularly those who have been historically underrepresented in clinical trials.

Join host Allison Kalloo, who has a vested interest in the conversation, the process, and the outcomes, as she embarks on this crucial journey. This premiere episode lays the groundwork for a series of thought-provoking discussions that challenge the status quo and champion innovative approaches to clinical research. Allison believes, and we believe, that you have a vested interest in these conversations too. What topics are most important to you? Reach out and let us know! Let's shape the future of clinical trials together. #ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Buzzsprout-15022245 Mon, 06 May 2024 22:00:00 -0400 1015 1 2 full false DEI - Still & Always a Vital Subject DEI - Still & Always a Vital Subject Welcome to No Ordinary Subjects. This podcast boldly explores the crucial intersection of diversity, equity, and inclusion in health, medicine, and clinical trials. This premiere episode lays the foundation for a series of candid and thought-provoking conversations that will delve into the often difficult, sometimes controversial, and always unusual subjects that shape our health experiences.

Prepare to hear from a broad spectrum of stakeholders who are deeply invested in this vital dialogue. I'll speak with those working tirelessly on the front lines of clinical care to improve health outcomes, the brilliant scientists dedicated to discovering better treatments and cures for disease, and the innovators in the biotech and pharmaceutical industries striving to bring life-changing interventions to market. We'll engage with policymakers shaping the future of healthcare, the regulators ensuring its safety and efficacy, and, most importantly, the individuals who step up to participate in clinical trials.

Because here's the truth: whether we are patients navigating diagnosed conditions or healthy volunteers contributing to vital research, we are not just subjects. We are partners. We are voices. We are the driving force behind meaningful change. Each of us has a story to tell, a perspective to share, and a crucial role to play in building a more equitable and inclusive healthcare system. Join us on 'No Ordinary Subjects' as we amplify those voices, challenge the status quo, and work together to create a healthier future— for all.

I'm your host, Allison Kalloo. I have been a changemaker and an entrepreneur in this space for more than a decade, and I am also a long-time participant in clinical trials. Let's get into it.

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Welcome to No Ordinary Subjects. This podcast boldly explores the crucial intersection of diversity, equity, and inclusion in health, medicine, and clinical trials. This premiere episode lays the foundation for a series of candid and thought-provoking conversations that will delve into the often difficult, sometimes controversial, and always unusual subjects that shape our health experiences.

Prepare to hear from a broad spectrum of stakeholders who are deeply invested in this vital dialogue. I'll speak with those working tirelessly on the front lines of clinical care to improve health outcomes, the brilliant scientists dedicated to discovering better treatments and cures for disease, and the innovators in the biotech and pharmaceutical industries striving to bring life-changing interventions to market. We'll engage with policymakers shaping the future of healthcare, the regulators ensuring its safety and efficacy, and, most importantly, the individuals who step up to participate in clinical trials.

Because here's the truth: whether we are patients navigating diagnosed conditions or healthy volunteers contributing to vital research, we are not just subjects. We are partners. We are voices. We are the driving force behind meaningful change. Each of us has a story to tell, a perspective to share, and a crucial role to play in building a more equitable and inclusive healthcare system. Join us on 'No Ordinary Subjects' as we amplify those voices, challenge the status quo, and work together to create a healthier future— for all.

I'm your host, Allison Kalloo. I have been a changemaker and an entrepreneur in this space for more than a decade, and I am also a long-time participant in clinical trials. Let's get into it.

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

]]> Allison Buzzsprout-15022227 Mon, 06 May 2024 22:00:00 -0400 425 1 1 trailer false